Drug Pricing

Drug Pricing Executive Action Is Unlikely: Evercore ISI

There is significant chatter in Washington D.C. that U.S. President Barack Obama could use his executive authority to regulate drug pricing, a “flash note” from Evercore ISI analyst Terry Haines says. But such an action is unlikely for three primary reasons, says the research note delivered to institutional investors earlier Wednesday.


Hot D.C. rumor: Obama may issue an executive order on drug prices
The high profile . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Saved Articles
X
TextTExtLInkTextTExtLInk

Subscribe to our mailing list

* indicates required

Opt out of occasional 3rd party offers


0